An inhibitor of glycogen phosphorylase
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Glycogen Phosphorylase Inhibitor

Item No. 17578

Technical Information
Formal Name
2-chloro-4,5-difluoro-N-[[[2-methoxy-5-[[(methylamino)carbonyl]amino]phenyl]amino]carbonyl]-benzamide
CAS Number
648926-15-2
Synonyms
  • GPI
Molecular Formula
C17H15ClF2N4O4
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 5 mg/mlDMSO: 5 mg/ml
λmax
238, 302 nm
SMILES
FC1=C(F)C=C(C(NC(NC2=C(OC)C=CC(NC(NC)=O)=C2)=O)=O)C(Cl)=C1
InChi Code
InChI=1S/C17H15ClF2N4O4/c1-21-16(26)22-8-3-4-14(28-2)13(5-8)23-17(27)24-15(25)9-6-11(19)12(20)7-10(9)18/h3-7H,1-2H3,(H2,21,22,26)(H2,23,24,25,27)
InChi Key
ROJNYKZWTOHRNU-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Product Description

    Glycogen phosphorylase inhibitor is a cell-permeable acyl urea first identified as an inhibitor of human liver glycogen phosphorylase (IC50 = 53 nM).1 It blocks glucagon-induced hepatic glycogenolysis in vivo.1 Glycogen phosphorylase inhibitor has been used to study glycogen utilization in human liver HepG2 cells, retinal explants, and human T lymphocyte Kit 225 cells.2,3,4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Klabunde, T., Wendt, K.U., Kadereit, D., et alAcyl ureas as human liver glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. J. Med. Chem. 48(20), 6178-6193 (2005).

    2. Cheng, A., Zhang, M., Gentry, M.S., et alA role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori’s disease. Genes Dev. 21(19), 2399-2409 (2007).

    3. Agathocleous, M., Love, N.K., Randlett, O., et alMetabolic differentiation in retinal cells. Nat. Cell Biol. 14(8), 859-864 (2012).

    4. Arrizabalaga, O., Lacerda, H.M., Zubiaga, A.M., et alRac1 protein regulates glycogen phosphorylase activation and controls interleukin (IL)-2-dependent T cell proliferation. The Journal of Biological Chemisty 287(15), 11878-11890 (2012).